Phibro Animal Health Corporation (PAHC)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$53.65
-4.44%
Mkt Cap $2.19B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 4, 2026 | $355.64M | $373.90M | +5.14% | $0.69 | $0.87 | +26.09% | — | — |
| Q4 2025 Nov 5, 2025 | $345.44M | $363.89M | +5.34% | $0.59 | $0.73 | +23.73% | — | — |
| Q3 2025 Aug 27, 2025 | $362.38M | $378.70M | +4.50% | $0.52 | $0.57 | +9.62% | — | — |
| Q2 2025 May 7, 2025 | $362.24M | $347.82M | -3.98% | $0.52 | $0.63 | +21.15% | — | — |
| Q1 2025 Feb 5, 2025 | $347.01M | $309.26M | -10.88% | $0.40 | $0.54 | +35.00% | — | — |
| Q4 2024 Nov 7, 2024 | $244.40M | $260.43M | +6.56% | $0.25 | $0.35 | +40.00% | — | — |
| Q3 2024 Aug 28, 2024 | $263.24M | $273.16M | +3.77% | $0.34 | $0.41 | +20.59% | — | — |
| Q2 2024 May 8, 2024 | $263.24M | $263.22M | -0.01% | $0.29 | $0.31 | +6.90% | — | — |
| Q1 2024 Feb 7, 2024 | $251.30M | $249.94M | -0.54% | $0.27 | $0.33 | +22.22% | — | — |
| Q4 2023 Nov 8, 2023 | $242.04M | $231.30M | -4.44% | $0.21 | $0.14 | -33.33% | — | — |
| Q3 2023 Aug 30, 2023 | $238.31M | $255.05M | +7.02% | $0.40 | $0.38 | -5.00% | — | — |
| Q2 2023 May 3, 2023 | $258.55M | $245.67M | -4.98% | $0.34 | $0.29 | -14.71% | — | — |
| Q1 2023 Feb 8, 2023 | $241.29M | $244.65M | +1.39% | $0.30 | $0.34 | +13.33% | — | — |
| Q4 2022 Nov 9, 2022 | $232.09M | $232.52M | +0.18% | $0.26 | $0.21 | -19.23% | — | — |
| Q3 2022 Aug 24, 2022 | $250.04M | $255.30M | +2.10% | $0.40 | $0.36 | -10.00% | — | — |
| Q2 2022 May 4, 2022 | $230.53M | $239.62M | +3.94% | $0.35 | $0.33 | -5.71% | — | — |
| Q1 2022 Feb 9, 2022 | $215.28M | $232.71M | +8.10% | $0.33 | $0.37 | +12.12% | — | — |
| Q4 2021 Nov 2, 2021 | $202.23M | $214.66M | +6.15% | $0.28 | $0.25 | -10.71% | — | — |
| Q3 2021 Aug 25, 2021 | $202.23M | $220.30M | +8.94% | $0.31 | $0.32 | +3.23% | — | — |
| Q2 2021 May 6, 2021 | $208.06M | $211.73M | +1.76% | $0.34 | $0.34 | +0.00% | — | — |